In vivo measurement of coronary circulation angiotensin-converting enzyme activity in humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Staniloae, Cezar ^a   Schwab, Andreas J ^b   Simard, André ^b   Gallo, Richard ^a   Dyrda, Ihor ^a   Gosselin, Gilbert ^a   Lespérance, Jacques ^a   Ryan, James W ^a   Dupuis, Jocelyn ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Angiography; Atherosclerosis; Coronary disease; Endothelial function

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVITY; HEART MUSCLE BLOOD FLOW; HUMAN; IN VIVO STUDY; INDICATOR DILUTION CURVE; MEASUREMENT; PRIORITY JOURNAL;

EID: 0037229541     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00452.2002     Document Type: Article

References (31)

1. 15O-labeled water washout from the heart. Circ Res 77: 1212-1221, 1995.
2. Caldwell JH, Martin GV, Raymond GM, and Bassingthwaighte JB. Regional myocardial flow and capillary permeability-surface area products are nearly proportional. Am J Physiol Heart Circ Physiol 267: H654-H666, 1994.
3. Caldwell PR, Seegal BC, Hsu KC, Das M, and Soffer RL. Angiotensin-converting enzyme: Vascular endothelial localization. Science 191: 1050-1051, 1976.
4. 3H]benzoyl-phenylalanyl-alanyl-proline by pulmonary angiotensin converting enzyme in vivo: Effects of bradykinin, SQ 14225 or acute hypoxia. J Pharmacol Exp Ther 217: 263-270, 1981.
5. Chobanian AV, Haudenschild CC, Nickerson C, and Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 15: 327-331, 1990.
6. Cousineau DF, Goresky CA, Rose CP, and Schwab AJ. Cardiac microcirculatory effects of β-adrenergic blockade during sympathetic stimulation. Circ Res 68: 997-1006, 1991.
7. Cousineau D, Rose CP, and Goresky CA. Plasma expansion effect on cardiac capillary and adrenergic exchange in intact dogs. J Appl Physiol 60: 147-153, 1986.
8. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, and Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94: 2756-2767, 1996.
9. Dupuis J, Goresky CA, Rose CP, Stewart DJ, Cernacek P, Schwab AJ, and Simard A. Endothelin-1 myocardial clearance, production, and effect on capillary permeability in vivo. Am J Physiol Heart Circ Physiol 273: H1239-H1245, 1997.
10. Dupuis J, Goresky CA, Rouleau JL, Bach GG, Simard A, and Schwab AJ. Kinetics of pulmonary uptake of serotonin during exercise in dogs. J Appl Physiol 80: 30-46, 1996.
11. Falkenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, Bachmann S, Danilov S, and Unger T. Cellular distribution of angiotensin- converting enzyme after myocardial infarction. Hypertension 25: 219-226, 1995.
12. Harris TR, Gervin CA, Burks D, and Custer P. Effects of coronary flow reduction on capillary-myocardial exchange in dogs. Am J Physiol Heart Circ Physiol 234: H679-H689, 1978.
13. Horvath IG, Cziraki A, Parkerson JB, Khan SU, and Catravas JD. Effect of acute coronary occlusion on the size of the dynamically perfused coronary capillary bed in the dog. Microvasc Res 56: 95-103, 1998.
14. Hoshida S, Kato J, Nishino M, Egami Y, Takeda T, Kawabata M, Tanouchi J, Yamada Y, and Kamada T. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 103: 630-633, 2001.
15. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Luscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, and Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 94: 258-265, 1996.
16. Merker MP, Dawson CA, Bongard RD, Roerig DL, Haworth ST, and Linehan JH. Angiotensin-converting enzyme preferentially hydrolyzes trans isomer of proline-containing substrate. J Appl Physiol 75: 1519-1524, 1993.
17. Orfanos SE, Armaganidis A, Glynos C, Psevdi E, Kaltsas P, Sarafidou P, Catravas JD, Dafni UG, Langleben D, and Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 102: 2011-2018, 2000.
18. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, and SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327: 669-677, 1992.
19. Pinto JE, Viglione P, and Saavedra JM. Autoradiographic localization and quantification of rat heart angiotensin converting enzyme. Am J Hypertens 4: 321-326, 1991.
20. Pitt BR, Lister G, Davies P, and Reid L. Correlation of pulmonary ACE activity and capillary surface area during post-natal development. J Appl Physiol 62: 2031-2041, 1987.
21. Reiber JHC, van der Zwet PMJ, von Land CD, Koning G, Van Meurs B, Buis B, and van Voorthuisen AE. Quantitative coronary arteriography: Equipment and technical requirements. In: Advances in Quantitative Coronary Arteriography, edited by Reiber JHC and Serruys PW. Dordrecht, The Netherlands: Kluwer Academic, 1993, p. 75-111.
22. Rose CP, Cousineau D, and Goresky CA. A clinically applicable method for the estimation of substrate transport in the coronary circulation in vivo. Circulation 72: IV81-IV88, 1985.
23. Rose CP and Goresky CA. Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation. Circ Res 39: 541-554, 1976.
24. Ryan JW, Ryan US, Schultz DR, Whitaker C, and Chung A. Subcellular localization of pulmonary angiotensin-converting enzyme (kininase II). Biochem J 146: 497-499, 1975.
25. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, and Blaine EH. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 91: 1453-1458, 1993.
26. Sullivan DR, Marwick TH, and Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119: 1262-1267, 1990.
27. The BARI Protocol. Protocol for the bypass angioplasty revascularization investigation. Circulation 84, Suppl V: V1-V7, 1991.
28. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, and Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 332: 481-487, 1995.
29. Vita JA, Yeung AC, Winniford M, Hodgson JM, Treasure CB, Klein JL, Werns S, Kern M, Plotkin D, Shih WJ, Mitchel Y, and Ganz P. Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease. Circulation 102: 846-851, 2000.
30. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, and Mendelsohn AO. Localization of angiotensin converting enzyme in rat heart. Circ Res 68: 141-149, 1991.
31. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.